Back
Sandoz Group AG Vs. NLS Pharmaceutics Industry Stock Comparison
Sell
23
SDZNY
Sandoz Group AG
Last Price:
45.61
Seasonality Move:
11.41%
Sell
4
NLSP
NLS Pharmaceutics
Last Price:
3.70
Seasonality Move:
37.9%
Sell
23
Sandoz Group AG (SDZNY)
is a Sell
Is Sandoz Group AG a Buy, Sell or Hold?
- The current Sandoz Group AG [SDZNY] share price is $45.52. The Score for SDZNY is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
- SDZNY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
4
NLS Pharmaceutics (NLSP)
is a Sell
Is NLS Pharmaceutics a Buy, Sell or Hold?
- The current NLS Pharmaceutics [NLSP] share price is $3.86. The Score for NLSP is 4, which is 92% below its historic median score of 50, and infers higher risk than normal.
- NLSP is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
SDZNY Stock Price Chart
What is Sandoz Group AG's stock price today?
-
The Sandoz Group AG share price today is $45.52
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SDZNY is experiencing selling pressure, which indicates risk of future bearish movement.
NLSP Stock Price Chart
What is NLS Pharmaceutics's stock price today?
-
The NLS Pharmaceutics share price today is $3.86
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NLSP is experiencing slight selling pressure.
SDZNY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.7 | Buy |
Relative Strength Index (14 RSI): | 62.55 | Buy |
Chaikin Money Flow: | -34032 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (41.51 - 44.29) | Buy |
Bollinger Bands (100): | (37.94 - 43.66) | Buy |
NLSP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.36 | Sell |
Relative Strength Index (14 RSI): | 32.5 | Sell |
Chaikin Money Flow: | -5786 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (4.35 - 5.17) | Sell |
Bollinger Bands (100): | (4.91 - 7.99) | Sell |
SDZNY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 44.23 | Buy |
20-day SMA: | 43.18 | Buy |
50-day SMA: | 42.73 | Buy |
200-day SMA: | 36.69 | Buy |
8-day EMA: | 44.27 | Buy |
20-day EMA: | 43.49 | Buy |
50-day EMA: | 42.47 | Buy |
200-day EMA: | 37.49 | Buy |
NLSP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 4.34 | Sell |
20-day SMA: | 4.68 | Sell |
50-day SMA: | 5.31 | Sell |
200-day SMA: | 8.59 | Sell |
8-day EMA: | 4.29 | Sell |
20-day EMA: | 4.64 | Sell |
50-day EMA: | 5.32 | Sell |
200-day EMA: | 10.29 | Sell |
Sandoz Group AG Earnings Growth & SDZNY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
NLS Pharmaceutics Earnings Growth & NLSP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Sandoz Group AG Technical Analysis
Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
NLS Pharmaceutics Technical Analysis
Oct 17 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
17 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |